# Lactoferrin Treatment in HIV Patients

> **NCT01830595** · PHASE2 · COMPLETED · sponsor: **Jason Baker** · enrollment: 55 (actual)

## Conditions studied

- HIV Infection

## Interventions

- **DRUG:** Recombinant Lactoferrin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01830595
- **Lead sponsor:** Jason Baker
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-09
- **Primary completion:** 2017-07
- **Final completion:** 2018-01
- **Target enrollment:** 55 (ACTUAL)
- **Last updated:** 2024-12-31

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01830595

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01830595, "Lactoferrin Treatment in HIV Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01830595. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*